FDA Advisory Panel Backs Cameron's New Defibrillators
Cameron Health Inc. announced Thursday that a U.S. Food and Drug Administration advisory panel had voted overwhelmingly to recommend that the FDA approve its new implantable defibrillators, despite mixed feedback in...To view the full article, register now.
Already a subscriber? Click here to view full article